Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00072150What this trial is testingPhase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell CarcinomaWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+7 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00397488What this trial is testingSunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Ended earlyNCT02122172What this trial is testingAfatinib in Advanced Refractory Urothelial CancerWho this might be right forDistal Urethral CancerProximal Urethral CancerRecurrent Bladder Cancer+6 more University of Chicago 32
Large-scale testing (Phase 3)Study completedNCT00014274What this trial is testingCombination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 238
Testing effectiveness (Phase 2)Study completedNCT00014144What this trial is testingS0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 31
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT01090466What this trial is testingGemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Cardiff University 15
Testing effectiveness (Phase 2)Study completedNCT00055835What this trial is testingS0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumWho this might be right forBladder CancerUrethral Cancer SWOG Cancer Research Network 7
Large-scale testing (Phase 3)Study completedNCT00003376What this trial is testingTwo-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 330
Post-approval studies (Phase 4)Looking for participantsNCT05962541What this trial is testingVesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)Who this might be right forNon-muscle-invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial CarcinomaHigh Risk Non-Muscle Invasive Bladder Urothelial Carcinoma University of Roma La Sapienza 327
Early research (Phase 1)Active Not RecruitingNCT02496208What this trial is testingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsWho this might be right forBladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Study completedNCT01191892What this trial is testingCarboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more Cardiff University 82
Early research (Phase 1)Active Not RecruitingNCT04963153What this trial is testingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and ImmunotherapyWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+17 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00066612What this trial is testingS0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 45
Testing effectiveness (Phase 2)Study completedNCT00661609What this trial is testingA Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT00006026What this trial is testingNitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 21
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05092958What this trial is testingTesting the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV StudyWho this might be right forAdvanced Bladder Urothelial CarcinomaAdvanced Renal Pelvis Urothelial CarcinomaAdvanced Ureter Urothelial Carcinoma+15 more National Cancer Institute (NCI) 654